A Case of Acute Myocarditis During Treatment With Anti-PD-1 Antibody Nivolumab in a Melanoma Patient

被引：1
|
作者：
Tadokoro, Tomonori [1 ]
Keshino, Eri [1 ]
Mohri, Masahiro [1 ]
机构：
[1] Kyushu Hosp, Japan Community Healthcare Org, Dept Cardiol, Kitakyushu, Fukuoka, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2016年 / 22卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2016.07.355
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6-1
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [1] Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
    Tadokoro, Tomonori
    Keshino, Eri
    Makiyama, Akitaka
    Sasaguri, Takakazu
    Ohshima, Koichi
    Katano, Harutaka
    Mohri, Masahiro
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (10)
  • [2] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    [J]. LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
  • [3] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    [J]. LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
  • [4] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Kaini Shen
    Yuehua Liu
    Xinxin Cao
    Daobin Zhou
    Jian Li
    [J]. Annals of Hematology, 2017, 96 : 687 - 688
  • [5] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Shen, Kaini
    Liu, Yuehua
    Cao, Xinxin
    Zhou, Daobin
    Li, Jian
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (04) : 687 - 688
  • [6] Innovative cancer immunotherapy, anti-PD-1 antibody Nivolumab
    Shibayama, Shiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S40 - S40
  • [7] Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease
    Maul, Lara V.
    Weichenthal, Michael
    Kaehler, Katharina C.
    Hauschild, Axel
    [J]. JOURNAL OF IMMUNOTHERAPY, 2016, 39 (04) : 188 - 190
  • [8] Durable remission with nivolumab, anti-PD-1 monoclonal antibody, in a patient with advanced thymic carcinoma
    Chae, Young Kwang
    Cho, Anderson
    Rhee, Kyunghoon
    Davis, Andrew
    Iams, Wade
    Bhave, Manali
    Cruz, Marcelo
    Park, Lee Chun
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma
    Nakamura, Kenta
    Ashida, Atsuko
    Kiniwa, Yukiko
    Okuyama, Ryuhei
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (09) : 887 - 895
  • [10] Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma
    Kenta Nakamura
    Atsuko Ashida
    Yukiko Kiniwa
    Ryuhei Okuyama
    [J]. Archives of Dermatological Research, 2022, 314 : 887 - 895
12345